Overview

Topical Lidocaine Patch in Low Back Pain

Status:
Completed

Trial end date:
1969-12-31

Target enrollment:

Participant gender:

Summary

Patients with acute or chronic Lower Back Pain (LBP) participated in a Phase IV clinical trial to assess the effectiveness of Lidoderm administered once daily (q24h) for 2 weeks in the treatment of acute and chronic LBP.

Phase:

Phase 4

Details

Lead Sponsor:

Endo Pharmaceuticals

Treatments:

Lidocaine